Evidence map›Paper›PMID 25721802›Full record

ArticleNature communications2015

Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells.

Carolyn Rydyznski, Keith A Daniels, Erik P Karmele, Taylor R Brooks, Sarah E Mahl, Michael T Moran, Caimei Li, Rujapak Sutiwisesak, Raymond M Welsh, Stephen N Waggoner

Abstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Trial
  4. Article
  5. Priming of Multiple HIV Neutralizing B Cell Precursors in Humans.medRxiv : the preprint server for health sciences · 2026
    Article
  6. Unconventional functions of natural killer cells in homeostasis and disease.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carolyn Rydyznski1] Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA [2] Immunology Graduate Program, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7038, Cincinnati, Ohio 45229, USA.
Keith A DanielsDepartment of Pathology, University of Massachusetts Medical School, 368 Plantation Street, ASC9-2014E, Worcester, Massachusetts, 01605, USA.
Erik P KarmeleCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA.
Taylor R BrooksCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA.
Sarah E MahlCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA.
Michael T Moran1] Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA [2] Immunology Graduate Program, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7038, Cincinnati, Ohio 45229, USA.
Caimei Li1] Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA [2] Immunology Graduate Program, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7038, Cincinnati, Ohio 45229, USA.
Rujapak SutiwisesakProgram in Immunology and Microbiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01605, USA.
Raymond M Welsh1] Department of Pathology, University of Massachusetts Medical School, 368 Plantation Street, ASC9-2014E, Worcester, Massachusetts, 01605, USA [2] Program in Immunology and Microbiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01605, USA.
Stephen N Waggoner1] Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 15012, Cincinnati, Ohio 45229, USA [2] Immunology Graduate Program, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7038, Cincinnati, Ohio 45229, USA.

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SELIN, LIISA KAARINA · 1999 to 2014
$19.1M
T cell and transgenic core U19AI109858 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HUSEBY, ERIC S · 2014 to 2018
$11.9M
ROLE OF ANGPTL4, AN ANGIOGENIC MEDIATOR, IN ARTHRITISP30AR047363 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI FLICK, MATTHEW J. · 2001 to 2015
$9.2M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Immunity and Virus DiseaseR37AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2004 to 2013
$4.0M
Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
A revolutionary vaccine approach to prevent HIV infection in substance abuseDP1DA038017 · NIDA · CINCINNATI CHILDRENS HOSP MED CTR · PI WAGGONER, STEPHEN N. · 2014 to 2018
$3.9M
Virus induced immunopathologyR01AI081675 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2009 to 2013
$2.0M
IMMUNITY AND VIRUS DISEASER01AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 1985 to 2003
$1.4M
NIAID NIH HHS AI007349NIAID NIH HHS AI017672NIAID NIH HHS AI046629NIAID NIH HHS AI109858NIAID NIH HHS HHSN272201300006CNIAID NIH HHS P01 AI046629NIAID NIH HHS R01 AI017672NIAID NIH HHS R01 AI081675NIAID NIH HHS R37 AI017672NIAID NIH HHS T32 AI007349NIAID NIH HHS U19 AI109858NIAMS NIH HHS AR47363NIAMS NIH HHS P30 AR047363NIDA NIH HHS DA038017NIDA NIH HHS DP1 DA038017NIDDK NIH HHS DK078392NIDDK NIH HHS DK78392NIDDK NIH HHS DK90971NIDDK NIH HHS P30 DK078392NIDDK NIH HHS P30 DK090971PHS HHS HHSN272201300006C
6 · The paper itself

Abstract

The goal of most vaccines is the induction of long-lived memory T and B cells capable of protecting the host from infection by cytotoxic mechanisms, cytokines and high-affinity antibodies. However, efforts to develop vaccines against major human pathogens such as HIV and HCV have not been successful, thereby highlighting the need for novel approaches to circumvent immunoregulatory mechanisms that limit the induction of protective immunity. Here, we show that mouse natural killer (NK) cells inhibit generation of long-lived virus-specific memory T- and B cells as well as virus-specific antibody production after acute infection. Mechanistically, NK cells suppressed CD4 T cells and follicular helper T cells (T(FH)) in a perforin-dependent manner during the first few days of infection, resulting in a weaker germinal centre (GC) response and diminished immune memory. We anticipate that innovative strategies to relieve NK cell-mediated suppression of immunity should facilitate development of efficacious new vaccines targeting difficult-to-prevent infections.

Indexed as

Lymphocytic choriomeningitis virusAnimalsAntibodies, MonoclonalArenaviridae InfectionsB-LymphocytesChromatography, GasCytokinesFlow CytometryImmunity, CellularImmunologic MemoryKiller Cells, NaturalMiceMice, Inbred C57BLMice, KnockoutViral Plaque AssayAntibodies, MonoclonalCytokines

Identifiers

PMID25721802
PMCPMC4346304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.